{"id":545328,"date":"2021-05-28T19:32:02","date_gmt":"2021-05-28T19:32:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=545328"},"modified":"2021-05-28T19:32:02","modified_gmt":"2021-05-28T19:32:02","slug":"systemic-sclerosis-market-analysis-market-size-trends-epidemiology-leading-companies-and-therapies-delveinsight","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/systemic-sclerosis-market-analysis-market-size-trends-epidemiology-leading-companies-and-therapies-delveinsight_545328.html","title":{"rendered":"Systemic Sclerosis Market Analysis, Market Size, Trends, Epidemiology, Leading Companies And Therapies | DelveInsight"},"content":{"rendered":"
\"Systemic<\/a><\/p>\n
\n
DelveInsight Business Research LLP<\/div>\n<\/div>\n<\/div>\n
DelveInsight\u2019s \u201cSystemic Sclerosis \u2013 Market Insights, Epidemiology, and Market Forecast-2030\u201d report delivers an in-depth understanding of the Systemic Sclerosis , historical and forecasted epidemiology as well as the Systemic Sclerosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n<\/div>\n

DelveInsight has launched a new report on “Systemic Sclerosis -Market Insights, Epidemiology, and Market Forecast-2030<\/strong>”.<\/p>\n

DelveInsight’s<\/span> “Systemic Sclerosis – Market Insights, Epidemiology, and Market Forecast-2030<\/strong><\/a><\/span>” report delivers an in-depth understanding of the Systemic Sclerosis, historical and forecasted epidemiology as well as the  Systemic Sclerosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/span><\/p>\n

Some of the key facts of the Report:<\/strong><\/p>\n

    \n
  1. \n

    As per the literature review, many geographical variations exist in SSc prevalence, such as a higher number of cases in the USA (276\/million) than in Japan and Europe, where a north-south gradient was clearly observed (France: 158\/million in 2001 and England: 88\/million in 2000).<\/p>\n<\/li>\n

  2. \n

    As per the study, SSc is a rare disease and is diagnosed in approximately 67 male patients and 265 female patients, per 100,000 people each year in the United States.<\/span><\/p>\n<\/li>\n

  3. \n

    SSc usually appears in women aged 30–40, and it occurs in slightly older men. In approximately 85% of cases, systemic sclerosis develops in individuals aged 20–60 years.<\/span><\/p>\n<\/li>\n<\/ol>\n

    Key benefits of the report:<\/strong><\/p>\n

    1.The Systemic Sclerosis market report covers a descriptive overview and comprehensive insight of the Systemic Sclerosis epidemiology and Systemic Sclerosis market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)<\/span><\/p>\n

    2.The Systemic Sclerosis market report provides insights on the current and emerging therapies.<\/span><\/p>\n

    3.Systemic Sclerosis market report provides a global historical and forecasted market covering drug outreach in 7MM.<\/span><\/p>\n

    4.The Systemic Sclerosis market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Systemic Sclerosis market.<\/span><\/p>\n

    Request for sample pages: https:\/\/www.delveinsight.com\/sample-request\/systemic-sclerosis-market<\/span><\/a>
    <\/a><\/strong><\/p>\n

    Systemic Sclerosis: Overview<\/strong><\/p>\n

    Systemic Sclerosis (SSc) is an autoimmune disease affecting the connective tissue which in turn damages the skin and internal organs. It is characterized by a distinctive pathogenic triad of microvascular damage, deregulation of innate and adaptive immunity, and generalized fibrosis in multiple organs.<\/span><\/p>\n

    The name of the condition comes from the Greek word, ‘sclera’ for hard and ‘derma’ for the skin. This hardening of the skin can be one of the first noticeable symptoms of the condition, due to excessive production of collagen. The excess of collagen can affect the skin, joints, tendons, and internal organs. It causes scarring and stops the affected parts of the body from functioning normally.<\/p>\n

    The key players involved in the Systemic Sclerosis  market<\/a>:<\/strong><\/p>\n

      \n
    1. \n

      Corbus Pharmaceuticals<\/span><\/p>\n<\/li>\n

    2. \n

      GenentechGalapagos NV<\/span><\/p>\n<\/li>\n

    3. \n

      Kyowa Hakko Kirin<\/span><\/p>\n<\/li>\n

    4. \n

      GlaxoSmithKlineKadmon Corporation<\/span><\/p>\n<\/li>\n

    5. \n

      Ifetroban<\/span><\/p>\n<\/li>\n

    6. \n

      Fibrocell<\/span><\/p>\n<\/li>\n

    7. \n

      Forbius<\/span><\/p>\n<\/li>\n<\/ol>\n

      The launch of the emerging therapies is expected to significantly impact the  Systemic Sclerosis treatment scenario in the upcoming years:-<\/strong><\/p>\n

      Drug covered<\/strong><\/p>\n

        \n
      1. \n

        Lenabasum<\/span><\/p>\n<\/li>\n

      2. \n

        Pirfenidone<\/span><\/p>\n<\/li>\n

      3. \n

        GLPG1690<\/span><\/p>\n<\/li>\n

      4. \n

        Brodalumab<\/span><\/p>\n<\/li>\n

      5. \n

        GSK2330811<\/span><\/p>\n<\/li>\n

      6. \n

        Vasculan<\/span><\/p>\n<\/li>\n

      7. \n

        FCX-013<\/span><\/p>\n<\/li>\n

      8. \n

        AVID200<\/span><\/p>\n<\/li>\n<\/ol>\n

        Request a free sample report @https:\/\/www.delveinsight.com\/sample-request\/systemic-sclerosis-market<\/span><\/a><\/strong><\/p>\n

        Table of Contents<\/strong><\/p>\n

        1. Report Introduction<\/span><\/p>\n

        2. Executive Summary<\/span><\/p>\n

        3. SWOT analysis<\/span><\/p>\n

        4. Systemic Sclerosis Patient Share (%) Overview at a Glance<\/span><\/p>\n

        5. Systemic Sclerosis Market Overview at a Glance<\/span><\/p>\n

        6. Systemic Sclerosis Disease Background and Overview<\/span><\/p>\n

        7. Systemic Sclerosis Epidemiology and Patient Population<\/span><\/p>\n

        8. Country-Specific Patient Population of Systemic Sclerosis <\/span><\/p>\n

        9. Systemic Sclerosis Current Treatment and Medical Practices<\/span><\/p>\n

        10. Unmet Needs<\/span><\/p>\n

        11. Systemic Sclerosis Emerging Therapies<\/span><\/p>\n

        12. Systemic Sclerosis Market Outlook<\/span><\/p>\n

        13. Country-Wise Systemic Sclerosis Market Analysis (2017–2030)<\/span><\/p>\n

        14. Market Access and Reimbursement of Therapies<\/span><\/p>\n

        15. Market drivers<\/span><\/p>\n

        16. Market barriers<\/span><\/p>\n

        17. Appendix<\/span><\/p>\n

        18. Systemic Sclerosis Report Methodology<\/span><\/p>\n

        19. DelveInsight Capabilities<\/span><\/p>\n

        20. Disclaimer<\/span><\/p>\n

        21. About DelveInsight<\/span><\/p>\n

        Related Reports:<\/strong><\/p>\n

        Systemic Sclerosis- Pipeline Insights, 2021<\/strong><\/p>\n

        “<\/span>Systemic Sclerosis- Pipeline Insight, 2021<\/span>” report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Systemic Sclerosis market. A detailed picture of the Systemic Sclerosis pipeline landscape is provided, which includes the disease overview and Systemic Sclerosis treatment guidelines.<\/span><\/p>\n

        Systemic Sclerosis -Epidemiology Forecast to 2030<\/strong><\/p>\n

        DelveInsight’s <\/span>‘Systemic Sclerosis- Epidemiology Forecast to 2030’ <\/span>report delivers an in-depth understanding of the disease, historical and forecasted Systemic Sclerosis{;l epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.<\/span><\/p>\n

        Media Contact<\/span>
        Company Name:<\/strong>         DelveInsight Business Research LLP<\/a>
        Contact Person:<\/strong> Kritika Rehani
        Email:<\/strong>         Send Email<\/a>
        Phone:<\/strong> 9193216187
        Address:<\/strong>304 S. Jones Blvd #2432
        City:<\/strong> Las Vegas
        State:<\/strong> Nevada
        Country:<\/strong> United States
        Website:<\/strong>         https:\/\/www.delveinsight.com\/<\/a><\/p>\n

        <\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

        DelveInsight Business Research LLP DelveInsight\u2019s \u201cSystemic Sclerosis \u2013 Market Insights, Epidemiology, and Market Forecast-2030\u201d report delivers an in-depth understanding of the Systemic Sclerosis , historical and forecasted epidemiology as well as the Systemic Sclerosis market trends in the United States, … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,435,405,406,404],"tags":[],"class_list":["post-545328","post","type-post","status-publish","format-standard","hentry","category-Business","category-Europe","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/545328","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=545328"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/545328\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=545328"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=545328"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=545328"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}